Skip to content

The Effect of a Group Exercise Intervention on Balance in People With Knee Osteoarthritis: a Pilot Study

The Effect of a Group Exercise Intervention on Balance in People With Knee Osteoarthritis: a Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06807541
Enrollment
32
Registered
2025-02-04
Start date
2025-02-18
Completion date
2025-06-19
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

knee osteoarthritis, balance, exercise

Brief summary

In this study, the investigators want to find out if a 12-week exercise program improves balance in people with knee osteoarthritis. This study will involve two visits to the School of Kinesiology at the University of the Fraser Valley (Chilliwack campus). Each visit will last approximately one hour. Participants will be asked to fill out questionnaires and complete a balance test. In between visits, participants will complete 12 weeks of an exercise program specifically designed for adults with osteoarthritis. Participants will do the exercise classes twice per week. Classes can be done in person or at home Each exercise class is 45-minutes long and consists of flexibility, strength, and coordination exercises. In each class there are options to either increase or decrease the intensity of each exercise to cater to varying fitness levels and fluctuating symptoms. Each exercise has an assisted (using a chair for balance), body weight, and resisted (weight or exercise tubing) option. Participants will fill out an exercise diary each week to let the investigators know what days they did the exercise classes, and whether they experienced any changes in their knee osteoarthritis symptoms.

Interventions

BEHAVIORALExercise intervention

45 minute exercise classes. Twice per week for 12 weeks.

Sponsors

University of the Fraser Valley
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Medial compartment knee osteoarthritis, diagnosed from a physician or meeting the American College of Rheumatology Clinical Classification Criteria for Osteoarthritis of the knee * Pass the Get Active Questionnaire to ensure that they are safe to begin an exercise program

Exclusion criteria

i) severe knee trauma, knee surgery, or intraarticular knee joint injections in the previous six months ii) active synovitis iii) concurrent neurological (i.e. Parkinson's disease, Alzheimer's dementia, or polyneuropathy), endocrine (i.e., diabetes mellitus) and/or vestibular disorders which may affect balance iv) chronic disease that may put them at risk during the exercise classes (i.e., history of heart failure, stroke, chronic obstructive lung disease) v) uncorrected visual impairment which may affect balance vi) an inflammatory rheumatic disease (i.e., rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic reactive arthritis)

Design outcomes

Primary

MeasureTime frameDescription
Balance- Community Balance and Mobility ScaleFrom enrolment until the end of the treatment at 12 weeks.Community Balance and Mobility Scale- scaled from 0 to 96, where higher scores indicate higher balance (better outcome).

Secondary

MeasureTime frameDescription
Symptoms- Western Ontario and McMaster University Osteoarthritis IndexFrom enrolment until the end of the treatment at 12 weeks.Western Ontario and McMaster University (WOMAC) Osteoarthritis Index- Scores range from 0 to 96 for the total WOMAC where 0 represents the best health status and 96 the worst possible status.
Symptoms- Oxford Knee ScoreFrom enrolment until the end of the treatment at 12 weeks.The Oxford Knee Score is scored from 0-48, where higher scores are a better outcome.

Countries

Canada

Contacts

Primary ContactGillian Hatfield, PhD
gillian.hatfield@ufv.ca1 604-504-7441

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026